Title: Molecular Diagnostics Market to grow at 8.1% CAGR from 2016 to 2023
1Molecular Diagnostics Market to see growth of
8.1 from 2016 to 2023Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2 Key Insights from Molecular Diagnostics Market
- Rampant use of advanced PoC (point of care)
diagnostics devices across the healthcare sector
will spur molecular diagnostics market growth. - Furthermore, heavy demand for personalized drugs
as well as companion diagnostics along with high
expenditure on activities pertaining to medical
diagnostics clinical research will drive the
market trends over the coming six years. - DNA/RNA Purification, PCR (Polymerase chain
reaction), and Real-Time PCR are some of the key
molecular diagnostics technologies. - Real time PCR is also expected to make
substantial contributions towards molecular
diagnostics market size, driven by breakthroughs
in clinical microbiology, molecular biology, and
instrumentation. - Contagious diseases such as tuberculosis,
hepatitis C, flu, RSV (Respiratory syncytial
virus), meningitis, hepatitis B, HPV (human
papillomavirus), Dengue, and STD (Sexually
Transmitted Disease) are projected to contribute
significantly towards molecular diagnostics
market revenue over the next few years.
3Continued...
- HPV is anticipated to nurture molecular
diagnostics industry growth over 2016-2023. Rise
in HPV infections across the globe is expected to
drive the growth. - APAC molecular diagnostics industry size is
expected to grow considerably over the coming
timeframe. - Rise in incidence of contagious diseases as well
HAIs (hospital acquired infections), high patient
population base, fast economic development, and
preventive healthcare legislations will be the
key driving factors. - Large acceptance of modern technologies along
with high investments across the healthcare
sector to improve the care services is expected
to accelerate Europe molecular diagnostics
industry growth. - Key industry participants include Johnson
Johnson, bioMerieux, Becton Dickinson, Abbott
Laboratories, Danaher Corporation, Cepheid,
Bio-Rad Laboratories, Bayer Healthcare, F.
Hoffmann-La Roche AG, Siemens Healthcare, Dako,
and Novartis.
4Germany Molecular diagnostics market size, by
technology, 2012-2023 (USD Million)
5Table of Content
Chapter 1. Methodology and Scope 1.1.
Research Methodology 1.1.1.
Initial data exploration 1.1.2. Statistical
model and forecast 1.1.3. Industry insights
and validation 1.1.4. Research scope and
assumptions 1.2. Data
Sources 1.2.1. Primary sources 1.2.2.
Secondary sources Chapter 2. Executive
Summary 2.1. Molecular Diagnostics industry
3600 synopsis, 2012 - 2023 2.1.1. Business
trends 2.1.2. Disease trends 2.1.3.
Technological trends 2.1.4. Regional trends
6Table of Content
Chapter 3. Molecular Diagnostics Market
Industry Insights 3.1. Industry
segmentation 3.2. Industry size and forecast,
2012 - 2023 3.3. Industry impact
forces 3.3.1. Growth drivers 3.3.1.1.
Technological advancements 3.3.1.2. Growing
POC demand 3.3.1.3. Increasing geriatric
population 3.3.1.4. Considerable RD
initiatives 3.3.2. Industry pitfalls
challenges 3.3.2.1. Unclear regulatory
landscape 3.3.2.2. Cost concerns
7Table of Content
3.4. Growth potential analysis 3.5. Regional
opportunities 3.6. Disease type
opportunities 3.7. Porters analysis 3.8.
PESTEL analysis 3.9. Company market share
analysis, 2015 3.9.1. Key product
landscape 3.9.2. Competitive landscape
8 Browse Full Market Research Report On Molecular
Diagnostics Market _at_ http//bit.ly/2oUDIou
Request for a Sample of this Research
Report _at_ https//www.gminsights.com/request-sample
/detail/434
9 Stay In Touch Website www.gminsights.com Soci
al Media